Search: WFRF:(Sampaio Filipa PhD 1985 )
> (2021) >
A model for evaluat...
A model for evaluating the economic value of prevention programs for illicit use of anabolic androgenic steroids
-
- Sampaio, Filipa, PhD, 1985- (author)
- Uppsala universitet,Socialmedicin/CHAP
-
- Ssegonja, Richard (author)
- Uppsala universitet,Socialmedicin/CHAP
-
- Thiblin, Ingemar (author)
- Uppsala universitet,Rättsmedicin
-
show more...
-
- Nystrand, Camilla (author)
- Uppsala universitet,Socialmedicin/CHAP
-
show less...
-
(creator_code:org_t)
- Elsevier, 2021
- 2021
- English.
-
In: Health Policy. - : Elsevier. - 0168-8510 .- 1872-6054. ; 125:6, s. 807-813
- Related links:
-
https://doi.org/10.1...
-
show more...
-
https://uu.diva-port... (primary) (Raw object)
-
https://doi.org/10.1...
-
https://urn.kb.se/re...
-
https://doi.org/10.1...
-
show less...
Abstract
Subject headings
Close
- Background: The illicit use of anabolic androgenic steroids (AAS) has become a societal concern. We developed a decision-analytic model for assessing the cost-effectiveness of preventive interventions targeting AAS-use. We used scenario analyses to demonstrate: a) the potential health economic consequences of AAS use in Sweden, and b) the cost-effectiveness of a hypothetical preventive intervention.Methods: A population-based cohort model compared a hypothetical preventive intervention targeting AAS with a 'no intervention' scenario, from a limited societal perspective. The model simulated how a cohort of 18 year-old males transitioned between different states and predicted their health status and complications until the age of 41. Health outcomes were estimated as quality-adjusted life-years (QALY). Costs included intervention costs, drug costs, and costs of complications.Results: Total yearly costs related to AAS use amounted to nearly half a million US$, with the largest cost borne by the healthcare sector. Results suggest that AAS prevention could entail large costs and benefits with a mean incremental cost-effectiveness ratio of $550 per QALY, in a scenario where the intervention would decrease the probability of initiating AAS use by 5%.Conclusion: Results show large AAS related costs, and suggest that the implementation of a preventive intervention could offer good value for money given different effectiveness scenarios. This model can be used to estimate the value of interventions targeting AAS use.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Hälsovetenskap -- Hälso- och sjukvårdsorganisation, hälsopolitik och hälsoekonomi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Health Sciences -- Health Care Service and Management, Health Policy and Services and Health Economy (hsv//eng)
Keyword
- Anabolic steroids
- Cost-effectiveness
- Economic evaluation
- Prevention
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database